Ausper Biopharma Co., Ltd.: Hepatitis B, Chronic trials
The registry lists 13 Hepatitis B, Chronic studies with Ausper Biopharma Co., Ltd. as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 8Phase 3 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) ParticipantsNot yet recruitingNCT07884864Phase 1
- A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)Not yet recruitingNCT07876856Phase 1/2
- A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis BRecruitingNCT07635186Phase 2
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.RecruitingNCT07600788Phase 1
- A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) ParticipantsRecruitingNCT07511218Phase 1
- Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 InjectionRecruitingNCT07146100
- A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)RecruitingNCT07137910Phase 2
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B DrugsRecruitingNCT07069569Phase 2
- Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)Active, not recruitingNCT07246889Phase 3
- A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)Active, not recruitingNCT06993480Phase 2
- Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)Active, not recruitingNCT06829329Phase 2
- Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).CompletedNCT06550128Phase 2
- A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) PatientsCompletedNCT06115993Phase 1/2